microRNAs: a new class of endogenous antimicrobials for the treatment of infections in cystic fibrosis and beyond

被引：0
|
作者：
Ye, Yunfei [1 ]
Sun, Yin He Richard [1 ]
Fitzpatrick, Fidelma [2 ]
Greene, Catherine M. . [1 ]
机构：
[1] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Lung Biol Grp, Dublin, Ireland
[2] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Dublin, Ireland
来源：
FUTURE MICROBIOLOGY | 2024年 / 19卷 / 12期
关键词：
antibiotic enhancing; antimicrobial resistance; cystic fibrosis; ESKAPE pathogens; microRNA; Pseudomonas aeruginosa; Staphylococcus aureus; therapeutics;
D O I：
10.1080/17460913.2024.2357971
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1041 / 1043
页数：3
相关论文
共 50 条
  • [31] Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
    Coriati, Adele
    Ma, Xiayi
    Sykes, Jenna
    Stanojevic, Sanja
    Ruseckaite, Rasa
    Lemonnier, Lydie
    Dehillotte, Clemence
    Tate, Jan
    Byrnes, Catherine Ann
    Bell, Scott C.
    Burgel, Pierre Regis
    Stephenson, Anne L.
    THORAX, 2023, 78 (03) : 242 - 248
  • [32] State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics
    Epps, Quovadis J.
    Epps, Kevin L.
    Young, David C.
    Zobell, Jeffery T.
    PEDIATRIC PULMONOLOGY, 2020, 55 (01) : 33 - 57
  • [33] Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches
    Klodzinska, Sylvia Natalie
    Priemel, Petra Alexandra
    Rades, Thomas
    Nielsen, Hanne Morck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10):
  • [34] New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis
    Scoffone, Viola Camilla
    Barbieri, Giulia
    Irudal, Samuele
    Trespidi, Gabriele
    Buroni, Silvia
    ANTIBIOTICS-BASEL, 2024, 13 (01):
  • [35] NEW MODALITIES IN THE TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY IN CYSTIC-FIBROSIS
    HEIJERMAN, HGM
    NETHERLANDS JOURNAL OF MEDICINE, 1992, 41 (3-4) : 105 - 109
  • [36] Effectiveness of home treatment for patients with cystic fibrosis: The intravenous administration of antibiotics to treat respiratory infections
    Termoz, A.
    Touzet, S.
    Bourdy, S.
    Decullier, E.
    Bouveret, L.
    Colin, C.
    Nove-Josserand, R.
    Reix, P.
    Cracowski, C.
    Pin, I.
    Bellon, G.
    Durieu, I.
    PEDIATRIC PULMONOLOGY, 2008, 43 (09) : 908 - 915
  • [37] Peptide dendrimers as "lead compounds" for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies
    Pompilio, Arianna
    Geminiani, Cristina
    Mantini, Paolo
    Siriwardena, Thissa N.
    Di Bonaventura, Ivan
    Reymond, Jean Louis
    Di Bonaventura, Giovanni
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1767 - 1782
  • [38] Effectiveness of different eradication treatment protocols for new-onset Pseudomonas aeruginosa in children with cystic fibrosis
    Sunman, Birce
    Emiralioglu, Nagehan
    Hazirolan, Gulsen
    Sener, Burcin
    Ozsezen, Beste
    Tural, Dilber A.
    Buyuksahin, Halime N.
    Guzelkas, Ismail
    Yalcin, Ebru
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    PEDIATRIC PULMONOLOGY, 2022, 57 (06) : 1456 - 1465
  • [39] Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Lehmann, Sylvia
    Pfannenstiel, Claus
    Friedrichs, Frank
    Kroeger, Kristina
    Wagner, Norbert
    Tenbrock, Klaus
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2014, 8 (05) : 141 - 149
  • [40] ISOLATION AND TREATMENT OF CYSTIC-FIBROSIS PATIENTS WITH LUNG INFECTIONS CAUSED BY PSEUDOMONAS-(BURKHOLDERIA)-CEPACIA AND MULTIRESISTANT PSEUDOMONAS-AERUGINOSA
    HOIBY, N
    NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (06) : 280 - 287
12345